-9.1%
T vs MRNA
+511.3%
-520.4%
-28.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -2.2% | +0.3% | -2.0% |
| 7D | -1.3% | +5.5% | -6.7% | -1.2% |
| 30D | +11.4% | +158.7% | -147.4% | +13.3% |
| 3M | +14.3% | +182.1% | -167.8% | +17.1% |
| 6M | -9.3% | +151.8% | -161.1% | -7.1% |
| YTD | +7.1% | +393.6% | -386.5% | +12.3% |
| 1Y | -9.1% | +499.5% | -508.6% | -3.7% |
| All | -9.1% | +511.3% | -520.4% | -3.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling